chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Cardiac failure congestive
Clinical narrative: CONGESTIVE HEART FAILURE; DETERIORATING LEFT UPPER CHAMBER OF MY HEART IN ADDITION TO FIB; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (Dose in series 1) (suspension for injection, intramuscular, batch number was not reported) dose was not reported, administered on 2021 for covid-19 prophylaxis. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. The patient reported that In 2021, when he received the vaccine, within 3 weeks he was hospitalized for the first time with a deteriorating left upper chamber of his heart in addition to fib. For the next 4 month, he was out of work and wearing a defibrillator vest for 4-5 months 24 hors a day, with multiple visits to his Cardiologist and Hospital stays. The patient was classified that he had congestive heart failure. This was coming from a family tree who that had no issues of heart disease or even took pills. The patient also reported that his current regimen was 12 pills 5 times a day to try and control his heart rate. He have had 2 cardioversion to try and fix his rate to help heal his heart. His last stint in the hospital on Aug 10th, he was admitted to hospital which was known to be the best in the area in cardiology. He was again given a cardioversion to try to correct his heart and again no success. He was then given a defibrillator installed in his chest to control his beats. After meeting with his Cardiologist and surgeons yesterday that were very bleak on a correction and they advised him to make a claim to the company. At this point the patient was struggling to live a normal life and no longer to able to run his own business. The patient reported  with concern for his life and was also looking for answers. The patient would be waiting for a reply. On an unspecified date, the patient experienced congestive heart failure (Dose in series 1), and deteriorating left upper chamber of my heart in addition to fib (Dose in series 1), and was hospitalized (date unspecified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the congestive heart failure and deteriorating left upper chamber of my heart in addition to fib was not reported. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition).; Sender's Comments: V0: Cardiac failure congestive, Atrial fibrillation -The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.
Sex: U
Vaccine: COVID19
Symptoms: Cardiac dysfunction, Hospitalisation
Clinical narrative: IN THE HOSPITAL FOR 18 TIMES; 20% HEART FUNCTION; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s(dose series 1) (suspension for injection, intramuscular, batch number was not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported and has been requested. No concomitant medications were reported.  The patient reported that has been having issues ever since got the vaccine and after being vaccinated the patient had 20% heart function. The patient had been in the hospital for 18 times since got the vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the 20% heart function and in the hospital for 18 times was not reported. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition). This report was associated with product quality complaint (PQC):90000337584.   \; Sender's Comments: V0: Cardiac dysfunction, Hospitalisation. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.
Age: 77.0
Sex: M
Vaccine: UNK
Symptoms: Arthralgia, Asthenia, Chills, Diarrhoea, Dizziness
Clinical narrative: diarrhea; weak; pain; dizziness/ lightheaded; fatigue/ tiredness; headache; redness or swelling at the injection site; redness or swelling at the injection site; fever; muscle/joint pain; chills; nausea; muscle/joint pain; This spontaneous case was reported by a patient and describes the occurrence of DIARRHOEA (diarrhea), ASTHENIA (weak), PAIN (pain), DIZZINESS (dizziness/ lightheaded) and FATIGUE (fatigue/ tiredness) in a 77-year-old male patient who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (batch no. 3042879) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Knee replacement ((years ago)). Previously administered products included for COVID-19 prophylaxis: Moderna COVID-19 vaccine (All previous doses - Moderna - no reactions to any previous Moderna vaccine). Past adverse reactions to the above products included No adverse effect with Moderna COVID-19 vaccine. Concurrent medical conditions included Blood pressure high (on medication for that.).    On 31-Aug-2024 at 1:00 PM, the patient received seventh dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (unknown route) 1 dosage form. On 01-Sep-2024, the patient experienced DIARRHOEA (diarrhea), ASTHENIA (weak), PAIN (pain), DIZZINESS (dizziness/ lightheaded), FATIGUE (fatigue/ tiredness), HEADACHE (headache), VACCINATION SITE ERYTHEMA (redness or swelling at the injection site), VACCINATION SITE SWELLING (redness or swelling at the injection site), PYREXIA (fever), ARTHRALGIA (muscle/joint pain), CHILLS (chills), NAUSEA (nausea) and MYALGIA (muscle/joint pain). At the time of the report, DIARRHOEA (diarrhea) and HEADACHE (headache) had resolved and ASTHENIA (weak), PAIN (pain), DIZZINESS (dizziness/ lightheaded), FATIGUE (fatigue/ tiredness), VACCINATION SITE ERYTHEMA (redness or swelling at the injection site), VACCINATION SITE SWELLING (redness or swelling at the injection site), PYREXIA (fever), ARTHRALGIA (muscle/joint pain), CHILLS (chills), NAUSEA (nausea) and MYALGIA (muscle/joint pain) was resolving.        For mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Unknown), the reporter did not provide any causality assessments.   Patient was taking medication for high blood pressure. Patient did not received any other vaccines in the 4 weeks prior to COVID-19 vaccine. He stated he did not vomit but came close to it. No treatment medication was reported.   This case was linked to US-MODERNATX, INC.-MOD-2024-773386 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2024-773386:Patient husband case
Age: 77.0
Sex: M
Vaccine: UNK
Symptoms: Fatigue, Injection site erythema, Injection site swelling, Myalgia, Nausea
Clinical narrative: diarrhea; weak; pain; dizziness/ lightheaded; fatigue/ tiredness; headache; redness or swelling at the injection site; redness or swelling at the injection site; fever; muscle/joint pain; chills; nausea; muscle/joint pain; This spontaneous case was reported by a patient and describes the occurrence of DIARRHOEA (diarrhea), ASTHENIA (weak), PAIN (pain), DIZZINESS (dizziness/ lightheaded) and FATIGUE (fatigue/ tiredness) in a 77-year-old male patient who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (batch no. 3042879) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Knee replacement ((years ago)). Previously administered products included for COVID-19 prophylaxis: Moderna COVID-19 vaccine (All previous doses - Moderna - no reactions to any previous Moderna vaccine). Past adverse reactions to the above products included No adverse effect with Moderna COVID-19 vaccine. Concurrent medical conditions included Blood pressure high (on medication for that.).    On 31-Aug-2024 at 1:00 PM, the patient received seventh dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (unknown route) 1 dosage form. On 01-Sep-2024, the patient experienced DIARRHOEA (diarrhea), ASTHENIA (weak), PAIN (pain), DIZZINESS (dizziness/ lightheaded), FATIGUE (fatigue/ tiredness), HEADACHE (headache), VACCINATION SITE ERYTHEMA (redness or swelling at the injection site), VACCINATION SITE SWELLING (redness or swelling at the injection site), PYREXIA (fever), ARTHRALGIA (muscle/joint pain), CHILLS (chills), NAUSEA (nausea) and MYALGIA (muscle/joint pain). At the time of the report, DIARRHOEA (diarrhea) and HEADACHE (headache) had resolved and ASTHENIA (weak), PAIN (pain), DIZZINESS (dizziness/ lightheaded), FATIGUE (fatigue/ tiredness), VACCINATION SITE ERYTHEMA (redness or swelling at the injection site), VACCINATION SITE SWELLING (redness or swelling at the injection site), PYREXIA (fever), ARTHRALGIA (muscle/joint pain), CHILLS (chills), NAUSEA (nausea) and MYALGIA (muscle/joint pain) was resolving.        For mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Unknown), the reporter did not provide any causality assessments.   Patient was taking medication for high blood pressure. Patient did not received any other vaccines in the 4 weeks prior to COVID-19 vaccine. He stated he did not vomit but came close to it. No treatment medication was reported.   This case was linked to US-MODERNATX, INC.-MOD-2024-773386 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2024-773386:Patient husband case
Age: 77.0
Sex: M
Vaccine: UNK
Symptoms: Pain, Pyrexia
Clinical narrative: diarrhea; weak; pain; dizziness/ lightheaded; fatigue/ tiredness; headache; redness or swelling at the injection site; redness or swelling at the injection site; fever; muscle/joint pain; chills; nausea; muscle/joint pain; This spontaneous case was reported by a patient and describes the occurrence of DIARRHOEA (diarrhea), ASTHENIA (weak), PAIN (pain), DIZZINESS (dizziness/ lightheaded) and FATIGUE (fatigue/ tiredness) in a 77-year-old male patient who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (batch no. 3042879) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Knee replacement ((years ago)). Previously administered products included for COVID-19 prophylaxis: Moderna COVID-19 vaccine (All previous doses - Moderna - no reactions to any previous Moderna vaccine). Past adverse reactions to the above products included No adverse effect with Moderna COVID-19 vaccine. Concurrent medical conditions included Blood pressure high (on medication for that.).    On 31-Aug-2024 at 1:00 PM, the patient received seventh dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (unknown route) 1 dosage form. On 01-Sep-2024, the patient experienced DIARRHOEA (diarrhea), ASTHENIA (weak), PAIN (pain), DIZZINESS (dizziness/ lightheaded), FATIGUE (fatigue/ tiredness), HEADACHE (headache), VACCINATION SITE ERYTHEMA (redness or swelling at the injection site), VACCINATION SITE SWELLING (redness or swelling at the injection site), PYREXIA (fever), ARTHRALGIA (muscle/joint pain), CHILLS (chills), NAUSEA (nausea) and MYALGIA (muscle/joint pain). At the time of the report, DIARRHOEA (diarrhea) and HEADACHE (headache) had resolved and ASTHENIA (weak), PAIN (pain), DIZZINESS (dizziness/ lightheaded), FATIGUE (fatigue/ tiredness), VACCINATION SITE ERYTHEMA (redness or swelling at the injection site), VACCINATION SITE SWELLING (redness or swelling at the injection site), PYREXIA (fever), ARTHRALGIA (muscle/joint pain), CHILLS (chills), NAUSEA (nausea) and MYALGIA (muscle/joint pain) was resolving.        For mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Unknown), the reporter did not provide any causality assessments.   Patient was taking medication for high blood pressure. Patient did not received any other vaccines in the 4 weeks prior to COVID-19 vaccine. He stated he did not vomit but came close to it. No treatment medication was reported.   This case was linked to US-MODERNATX, INC.-MOD-2024-773386 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2024-773386:Patient husband case
Age: 1.33
Sex: F
Vaccine: DTAPIPVHIB
Symptoms: No adverse event, Product preparation issue
Clinical narrative: pentacel that was accidentally administered without the ACT-HIB component to a patient with no reported adverse event; Initial information received on 29-Aug-2024 regarding an unsolicited valid non-serious case received from an other health professional.  This case involves a 16 months old female patient where diphtheria/tetanus/5 hybrid ac pertussis/ipv(vero)/hib(prp/t) vaccine [Pentacel (vero)] that was accidentally administered without the act-hib component to a patient with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 29-Aug-2024, the patient received 0.5 ml (strength- standard) dose of suspect diphtheria/tetanus/5 hybrid ac pertussis/IPV(VERO)/HIB(PRP/T) vaccine Powder and suspension for suspension for injection (lot- UJ972AA and expiry date- 10-NOV-2024) via intramuscular route in the left thigh for Immunisation (single component of a two-component product administered) (latency- same day).  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 11.0
Sex: F
Vaccine: MEN
Symptoms: No adverse event, Product storage error
Clinical narrative: Excursion limits : -7°C for 52 minutes with no adverse event; MenQuadfi was given to a patient this morning with no adverse event; Initial information received on 29-Aug-2024 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 11 years old female patient who received MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE [MENQUADFI] vaccine was this morning post excursion with no adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR 3-COMPONENT, TETANUS VACCINE TOXOID (BOOSTRIX) for Immunisation.  On an unknown date the MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE, excursion limits : -7°c for 52 minutes with no adverse event (product storage error).  On 29-Aug-2024, the patient received a dose 0.5 ml of suspect MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE, Solution for injection  (lot U8370AA and expiry 30-Apr-2028) (strength: unknown) post excursion (poor quality product administered) (latency same day) via intramuscular route in the left deltoid for prophylactic Vaccination.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: U
Vaccine: RAB
Symptoms: No adverse event, Product dose omission issue
Clinical narrative: Patient missed Day 7 dose with no adverse event; Initial information received on 30-Aug-2024 regarding an unsolicited valid  non-serious case received from a pharmacist.  This case involves an unknown age/gender patient who missed day 7 dose of RABIES (HDC) VACCINE [IMOVAX RABIES] with no adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient missed a  dose of suspect RABIES (HDC) VACCINE, Powder and solvent for suspension for injection (dose, strength, route, lot and expiry:unknnown) (routine immunisation schedule not administered) (unknown latency) in unknown administration site for prophylactic vaccination.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: F
Vaccine: VARZOS
Symptoms: Pyrexia
Clinical narrative: Low grade fever; This non-serious case was reported by a consumer via call center representative and described the occurrence of low grade fever in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 14th March 2024).   In JUL-2024, the patient received the 2nd dose of Shingrix. In JUL-2024, less than a month after receiving Shingrix, the patient experienced low grade fever (Verbatim: Low grade fever). The outcome of the low grade fever was unknown.   It was unknown if the reporter considered the low grade fever to be related to Shingrix.     It was unknown if the company considered the low grade fever to be related to Shingrix.   Additional Information: GSK Receipt Date: 29-AUG-2024 The patient stated that ever since she got the second shot of Shingrix in July 2024 she had been running a low grade fever and it had been since July 2024.
Sex: F
Vaccine: RSV
Symptoms: Extra dose administered
Clinical narrative: second dose was given 8-27-2024; This non-serious case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 64-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   Previously administered products included Arexvy (patient received a first dose of Arexvy during fall 2023).   On 27-AUG-2024, the patient received the 2nd dose of Arexvy. On 27-AUG-2024, an unknown time after receiving Arexvy, the patient experienced extra dose administered (Verbatim: second dose was given 8-27-2024). The outcome of the extra dose administered was unknown.   Additional Information: GSK Receipt Date: 29-AUG-2024 Nurse called to report a patient received a first dose and a second dose was given, which led to extra dose administered. The reporter consented to follow up. Initials, exact vaccination date for the first dose were asked and declined not available at moment of call.
Age: 1.25
Sex: M
Vaccine: DTAP
Symptoms: Febrile convulsion, Pyrexia
Clinical narrative: 11/18/17 Mom called and described patients as having a fever and possible seizure. 3:44pm EMS called and by the time the ambulance came patient was awake, playful and alert.brought to  ER. 6:44pm  was getting ready to b discharged from the ER and diagnosed with febrile seizure from viral infection  per mom. No records from ER were received. Patient did not come in for a followup visit after adverse event and ER visit.
Age: 57.0
Sex: F
Vaccine: UNK
Symptoms: Blister, Paraesthesia, Pruritus, Rash maculo-papular
Clinical narrative: Herpetic type lesions , on face unilateral . Several areas . Itching tingling . Maculo papilar  small clusters
Age: 78.0
Sex: F
Vaccine: VARZOS
Symptoms: Hyperaesthesia, Injection site erythema, Injection site rash, Pain, Skin warm
Clinical narrative: Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Additional Details: red rash on injection site. some pain on touch. warm to touch. 3in x 4in area on left arm. no other symptoms
Age: 70.0
Sex: F
Vaccine: PPV
Symptoms: Dizziness, Flushing, Headache, Hyperhidrosis, Injection site erythema
Clinical narrative: Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Body Aches Generalized-Medium, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fever-Mild, Systemic: Flushed / Sweating-Severe, Systemic: Headache-Medium, Systemic: Unable to Sleep-Medium, Systemic: Weakness-Medium, Additional Details: Pt said she woke up in the middle of the night with her entire bed drenched in sweat and she also experienced nightmares which is not usual., Other Vaccines:  VaccineTypeBrand: Fluzone High Dose Triv; Manufacturer: ; LotNumber: ; Route: ; BodySite: ; Dose: ; VaxDate: UNKNOWN
Age: 70.0
Sex: F
Vaccine: PPV
Symptoms: Injection site pain, Injection site swelling, Night sweats, Nightmare, Pyrexia
Clinical narrative: Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Body Aches Generalized-Medium, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fever-Mild, Systemic: Flushed / Sweating-Severe, Systemic: Headache-Medium, Systemic: Unable to Sleep-Medium, Systemic: Weakness-Medium, Additional Details: Pt said she woke up in the middle of the night with her entire bed drenched in sweat and she also experienced nightmares which is not usual., Other Vaccines:  VaccineTypeBrand: Fluzone High Dose Triv; Manufacturer: ; LotNumber: ; Route: ; BodySite: ; Dose: ; VaxDate: UNKNOWN
Age: 70.0
Sex: F
Vaccine: PPV
Symptoms: Sleep disorder
Clinical narrative: Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Body Aches Generalized-Medium, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fever-Mild, Systemic: Flushed / Sweating-Severe, Systemic: Headache-Medium, Systemic: Unable to Sleep-Medium, Systemic: Weakness-Medium, Additional Details: Pt said she woke up in the middle of the night with her entire bed drenched in sweat and she also experienced nightmares which is not usual., Other Vaccines:  VaccineTypeBrand: Fluzone High Dose Triv; Manufacturer: ; LotNumber: ; Route: ; BodySite: ; Dose: ; VaxDate: UNKNOWN
Age: 71.0
Sex: M
Vaccine: TDAP
Symptoms: Cough, Injection site erythema, Injection site pain
Clinical narrative: Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: cough-Mild, Other Vaccines:  VaccineTypeBrand: moderna 24/25 spikevax; Manufacturer: moderna; LotNumber: 3042439; Route: im; BodySite: left deltoid; Dose: ; VaxDate: 08/28/2024, VaccineTypeBrand: fluzone; Manufacturer: fluzone; LotNumber: u8429da; Route: im; BodySite: right  deltoid; Dose: ; VaxDate: 08/28/2024
Age: 68.0
Sex: M
Vaccine: FLU4
Symptoms: Extra dose administered
Clinical narrative: Systemic: see below-Mild, Additional Details: pt wife register patient online for fluzone-high dose and both patient and patient's wife were told that fluzone high dose will be given before it was administer and neither one said anyrhing. On a phone conversation after they both left the wife said her husband got fluzone high dose at the doctor 48 hours ago. This information was given after the administration of vaccine., Other Vaccines:  VaccineTypeBrand: fluzone high dose; Manufacturer: sanofi pasteur inc; LotNumber: ut8463aa; Route: intramuscular; BodySite: left arm; Dose: ; VaxDate: UNKNOWN
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Cellulitis, Injection site bruising, Injection site erythema, Injection site pain
Clinical narrative: Site: Bruising at Injection Site-Medium, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: muscle tingling, weakness, and soreness up and down her entire arm-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Additional Details: Patient noticed a hot red raised area at injection site hours after the injection.  It was the size of a silver dollar. Two days later it was 4 inches in diameter and continued to grow.  Her entire arm was weak and sore.  She felt she was developing cellulitis.  She went to the local hospital emergency room, where the doctor confirmed diagnosis of cellulitis and prescribed an antibiotic.  She believes it was due to improper technique and wants a call from corporate.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site swelling, Muscular weakness, Pain in extremity, Paraesthesia
Clinical narrative: Site: Bruising at Injection Site-Medium, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: muscle tingling, weakness, and soreness up and down her entire arm-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Additional Details: Patient noticed a hot red raised area at injection site hours after the injection.  It was the size of a silver dollar. Two days later it was 4 inches in diameter and continued to grow.  Her entire arm was weak and sore.  She felt she was developing cellulitis.  She went to the local hospital emergency room, where the doctor confirmed diagnosis of cellulitis and prescribed an antibiotic.  She believes it was due to improper technique and wants a call from corporate.
Age: 68.0
Sex: F
Vaccine: FLU4
Symptoms: Hypoaesthesia, Injection site pain, Pain in extremity, Paraesthesia
Clinical narrative: Site: Pain at Injection Site-Medium, Systemic: Numbness (specify: facial area, extremities)-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild, Additional Details: numbness and tingling and pain right arm.
Age: 71.0
Sex: M
Vaccine: FLUA4
Symptoms: Injected limb mobility decreased, Injection site pain, Pain in extremity
Clinical narrative: Site: Pain at Injection Site-Severe, Systemic: Pain in left arm started on august 31,2024. Patient came in 9/1/24 stated he cannot move his left arm-Severe, Additional Details: Patient received 2 vaccines (prevnar 20 and fluad trivalent) on august 29th, 2024. Patient came in today 9/1/24 stated he started to feel pain on august 31st, 2024 and he cannot move his left arm. I advised patient to go to the ER so a doctor can check it out. He picked up some NSAIDs, but I advised him he needs professional attention from an MD.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Arthralgia, Pain, Pain in extremity
Clinical narrative: Systemic: Abdominal Pain-Medium, Systemic: body pain at hip joint see below for more information-Medium, Systemic: Joint Pain-Medium, Additional Details: patient has left hip pain radiating to abdomen and back and upper leg, Other Vaccines:  VaccineTypeBrand: fluzone hd 2024-2025; Manufacturer: sanofi; LotNumber: u8429da; Route: intramuscular; BodySite: left deltoid; Dose: 1; VaxDate: UNKNOWN
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Vomiting
Clinical narrative: Systemic: Nausea-Mild, Systemic: Vomiting-Mild, Additional Details: Patient complained he was feeling lightheaded.  We observed for  a few minutes and then he threw up. Said he felt better afterwards. His father was with him and said it was a common experience in the family .Patient felf fine ad they left . we will check in with him tomorrow, Other Vaccines:  VaccineTypeBrand: flucelvax; Manufacturer: ; LotNumber: 946584; Route: im; BodySite: left arm; Dose: ; VaxDate: UNKNOWN
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Rash
Clinical narrative: Site: Itching at Injection Site-Mild, Additional Details: Patient claimed she got rash on arms and legs but She didn't seem to concerned about it just wanted us to know
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Dyspnoea, Headache, Nausea
Clinical narrative: Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Dizziness / Lightheadness-Severe, Systemic: Headache-Medium, Systemic: Nausea-Severe, Systemic: Vomiting-Medium, Systemic: Weakness-Medium, Other Vaccines:  VaccineTypeBrand: flucelvax; Manufacturer: seqirus; LotNumber: 388521; Route: intramuscular; BodySite: right arm; Dose: 1; VaxDate: 09/01/2024
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Dizziness / Lightheadness-Severe, Systemic: Headache-Medium, Systemic: Nausea-Severe, Systemic: Vomiting-Medium, Systemic: Weakness-Medium, Other Vaccines:  VaccineTypeBrand: flucelvax; Manufacturer: seqirus; LotNumber: 388521; Route: intramuscular; BodySite: right arm; Dose: 1; VaxDate: 09/01/2024
Age: 20.0
Sex: F
Vaccine: TDAP
Symptoms: Dizziness, Fall, Fatigue, Flushing, Hyperhidrosis
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Hypotension-Medium, Additional Details: After her Pfizer vaccine, she requested for Tdap vaccine to be in the same arm. Pt was alert and oriented, no sign of stress or nervousness. After applying the 2nd band aid, pt proceed to fall over her chair face down and momentarily got up on her own. She claimed to not have had breakfast so rph provided some candy and patient had a bottle of water. After a 5 minutes patient passed out again in the present of her parents and pharmamcy staff. EMT was called. Pt was transported to hospital.
Age: 20.0
Sex: F
Vaccine: TDAP
Symptoms: Hypotension, Lethargy, Loss of consciousness, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Hypotension-Medium, Additional Details: After her Pfizer vaccine, she requested for Tdap vaccine to be in the same arm. Pt was alert and oriented, no sign of stress or nervousness. After applying the 2nd band aid, pt proceed to fall over her chair face down and momentarily got up on her own. She claimed to not have had breakfast so rph provided some candy and patient had a bottle of water. After a 5 minutes patient passed out again in the present of her parents and pharmamcy staff. EMT was called. Pt was transported to hospital.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19, FLU3
Symptoms: Asthenia, Hypoaesthesia, Injection site pain, Paraesthesia
Clinical narrative: Site: Pain at Injection Site-Severe, Systemic: Numbness (specify: facial area, extremities)-Severe, Systemic: Tingling (specify: facial area, extemities)-Severe, Systemic: Weakness-Severe
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19, FLU3
Symptoms: Myelitis transverse
Clinical narrative: Site: Pain at Injection Site-Severe, Systemic: Numbness (specify: facial area, extremities)-Severe, Systemic: Tingling (specify: facial area, extemities)-Severe, Systemic: Weakness-Severe
Age: 57.0
Sex: M
Vaccine: FLUR4
Symptoms: Incontinence
Clinical narrative: Systemic: Incontinence-Medium, Other Vaccines:  VaccineTypeBrand: Comirnaty 2024-2025; Manufacturer: Pfizer; LotNumber: LM2222; Route: IM; BodySite: Arm; Dose: 1; VaxDate: 08/30/2024
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Rash
Clinical narrative: Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash Generalized-Medium
Age: 27.0
Sex: U
Vaccine: COVID19
Symptoms: Dizziness, Flushing, Hyperhidrosis
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Medium, Other Vaccines:  VaccineTypeBrand: Flucelvax; Manufacturer: ; LotNumber: ; Route: ; BodySite: ; Dose: ; VaxDate: UNKNOWN, VaccineTypeBrand: Jynneos; Manufacturer: ; LotNumber: ; Route: ; BodySite: ; Dose: ; VaxDate: UNKNOWN
Age: 16.0
Sex: M
Vaccine: COVID19-2
Symptoms: Anaphylactic reaction
Clinical narrative: Systemic: Allergic: Anaphylaxis-Severe
Age: 16.0
Sex: M
Vaccine: FLUC4
Symptoms: Anaphylactic reaction
Clinical narrative: Systemic: Allergic: Anaphylaxis-Severe
Age: 28.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chills, Dizziness, Dizziness postural, Dyspnoea, Flushing
Clinical narrative: Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Body Aches Generalized-Medium, Systemic: Chills-Medium, Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Medium, Systemic: Headache-Medium, Systemic: Tachycardia-Severe, Systemic: Unable to Sleep-Medium, Additional Details: when lies down heart rate is 90, when stand up hr goes up to or higher than  140. -  mum adviced to seek medical advice immediately.
Age: 28.0
Sex: F
Vaccine: COVID19-2
Symptoms: Headache, Hyperhidrosis, Pain, Sleep disorder, Syncope
Clinical narrative: Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Body Aches Generalized-Medium, Systemic: Chills-Medium, Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Medium, Systemic: Headache-Medium, Systemic: Tachycardia-Severe, Systemic: Unable to Sleep-Medium, Additional Details: when lies down heart rate is 90, when stand up hr goes up to or higher than  140. -  mum adviced to seek medical advice immediately.
Age: 28.0
Sex: F
Vaccine: COVID19-2
Symptoms: Tachycardia, Unresponsive to stimuli
Clinical narrative: Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Body Aches Generalized-Medium, Systemic: Chills-Medium, Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Medium, Systemic: Headache-Medium, Systemic: Tachycardia-Severe, Systemic: Unable to Sleep-Medium, Additional Details: when lies down heart rate is 90, when stand up hr goes up to or higher than  140. -  mum adviced to seek medical advice immediately.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site cellulitis, Injection site erythema, Injection site swelling
Clinical narrative: Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Additional Details: patient called today to inform that she received the moderna vaccine on 08/30/2024. she said that night there was swelling and redness the size of a quarter at the site of injection. the next day, the swelling grew to 4 inches and by sunday it was just spreading more. pt says she took benadryl thinking it an allergic reaction. so, on sunday she went to the er and she was told that it was cellulitus. she was prescribed cephalexin which she is currently taking. she said she was wiped with alcohol.
Age: 74.0
Sex: M
Vaccine: FLU4
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Site: Pain at Injection Site-Mild, Site: Swelling at Injection Site-Mild
Age: 76.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Mobility decreased, Pain in extremity
Clinical narrative: Site: Pain at Injection Site-Medium, Additional Details: Patient complains of pain in the arm after getting second dose of covid vaccine in 2021. Still unable to move arm up and down, has limitations
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Cerebrovascular accident
Clinical narrative: Systemic: Stroke-Severe, Additional Details: Patient was hospitalized for stroke day after receiving the vaccine
Age: 61.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site swelling
Clinical narrative: Site: Swelling at Injection Site-Medium
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain
Clinical narrative: Systemic: Abdominal Pain-Severe
Age: 29.0
Sex: F
Vaccine: TDAP
Symptoms: Arthralgia, Injected limb mobility decreased
Clinical narrative: Systemic: Joint Pain-Medium, Additional Details: Patient describes severe pain at L shoulder that is deep and excruciating. Some limited mobility due to the pain. Patient is going to ER today based on my recommendations.
Age: 67.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site bruising, Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Site: Bruising at Injection Site-Medium, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium
Age: 23.0
Sex: M
Vaccine: FLUC4
Symptoms: Flushing, Hyperhidrosis, Presyncope, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Additional Details: Pt had flu vaccine, a few minutes later, was drawing blood and vasovagal event occurred. Assuming due to blood draw (for other service), however possibly related to the vaccine. Also it was the trivalent vaccine (not drop down option).
Age: 23.0
Sex: M
Vaccine: FLUC4
Symptoms: Venipuncture
Clinical narrative: Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Additional Details: Pt had flu vaccine, a few minutes later, was drawing blood and vasovagal event occurred. Assuming due to blood draw (for other service), however possibly related to the vaccine. Also it was the trivalent vaccine (not drop down option).
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Injection site bruising, Injection site erythema, Injection site induration
Clinical narrative: Site: Bruising at Injection Site-Severe, Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Nausea-Severe, Systemic: Unable to Sleep-Severe, Additional Details: Patient came to the pharmacy, presented with severe swelling, pain, brusing radiating from upper arm to past elbow.  Injection site had severe swelling and hard to touch (size of a golf ball)..patient also complained of nausea, and uable to sleep due to pain in arm., Other Vaccines:  VaccineTypeBrand: fluzone High dose triv 24-25; Manufacturer: sanofi-pasteur; LotNumber: u8429aa; Route: im; BodySite: left deltoid; Dose: ; VaxDate: UNKNOWN
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site swelling, Lethargy, Nausea, Sleep disorder
Clinical narrative: Site: Bruising at Injection Site-Severe, Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Nausea-Severe, Systemic: Unable to Sleep-Severe, Additional Details: Patient came to the pharmacy, presented with severe swelling, pain, brusing radiating from upper arm to past elbow.  Injection site had severe swelling and hard to touch (size of a golf ball)..patient also complained of nausea, and uable to sleep due to pain in arm., Other Vaccines:  VaccineTypeBrand: fluzone High dose triv 24-25; Manufacturer: sanofi-pasteur; LotNumber: u8429aa; Route: im; BodySite: left deltoid; Dose: ; VaxDate: UNKNOWN
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Seizure
Clinical narrative: Systemic: Seizure-Mild, Additional Details: Patient felt dizzy after receiving vaccines and was sitting in the waiting area after. After <5 min she seized in the chair., Other Vaccines:  VaccineTypeBrand: Flublock Trivalent; Manufacturer: Sanofi-Pasteur; LotNumber: U8432AA; Route: IM; BodySite: Left Arm; Dose: 1; VaxDate: 09/04/2024
Age: 69.0
Sex: M
Vaccine: RSV
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild
Age: 67.0
Sex: F
Vaccine: RSV
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Anaphylactic reaction, Arthralgia, Asthenia, Autoimmune disorder
Clinical narrative: Site: Bruising at Injection Site-Mild, Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Allergic: Anaphylaxis-Mild, Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild, Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Allergic: Itch Generalized-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Systemic: Allergic: Rash Generalized-Mild, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Mild, Systemic: Abdominal Pain-Mild, Systemic: Autoimmune Disease (diagnosed by MD)-Mild, Systemic: Bell's Palsy-Mild, Systemic: Blood Disorder  (diagnosed by MD)-Mild, Systemic: Body Aches Generalized-Mild, Systemic: Cardiac Disorder (diagnosed by MD)-Mild, Systemic: Chest Tightness / Heaviness / Pain-Mild, Systemic: Chills-Mild, Systemic: Confusion-Mild, Systemic: Diarrhea-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Fever-Mild, Systemic: patient eyes rolled in the back of the head and patient lost consciousness and went to ER in ambulance and patient is still there being checked out and may stay over night they did rule out a stroke-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Headache-Mild, Systemic: Heart Attack-Mild, Systemic: Hypertension-Mild, Systemic: Hyperventilation-Mild, Systemic: Hypotension-Mild, Systemic: Joint Pain-Mild, Systemic: Lymph Node Swelling-Mild, Systemic: MIS (Multisystem Inflammatory Syndrome)(diagnosed by MD)-Mild, Systemic: Nausea-Mild, Systemic: Neurological Disorder (diagnosed by MD)-Mild, Systemic: Numbness (specify: facial area, extremities)-Mild, Systemic: Seizure-Mild, Systemic: Shakiness-Mild, Systemic: Stroke-Mild, Systemic: Tachycardia-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild, Systemic: Tinnitus-Mild, Systemic: Unable to Sleep-Mild, Systemic: Visual Changes/Disturbances-Mild, Systemic: Vomiting-Mild, Systemic: Weakness-Mild, Additional Details: pt wife  needs to be contacted but pt was alert and in the hospital when called and checked on earlier, Other Vaccines:  VaccineTypeBrand: arexxy; Manufacturer: glaxosmith kline; LotNumber: 29z7e; Route: im; BodySite: left; Dose: 1; VaxDate: 09/04/2024, VaccineTypeBrand: shingrix; Manufacturer: glaxosmithkline; LotNumber: 4n9pf; Route: im; BodySite: left; Dose: 1; VaxDate: 09/04/2024, VaccineTypeBrand: tdap; Manufacturer: glaxosmithkline; LotNumber: cx4hl; Route: im; BodySite: right; Dose: 1; VaxDate: 09/04/2024
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Bell's palsy, Blood disorder, Cardiac disorder, Cerebrovascular accident, Chest discomfort
Clinical narrative: Site: Bruising at Injection Site-Mild, Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Allergic: Anaphylaxis-Mild, Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild, Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Allergic: Itch Generalized-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Systemic: Allergic: Rash Generalized-Mild, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Mild, Systemic: Abdominal Pain-Mild, Systemic: Autoimmune Disease (diagnosed by MD)-Mild, Systemic: Bell's Palsy-Mild, Systemic: Blood Disorder  (diagnosed by MD)-Mild, Systemic: Body Aches Generalized-Mild, Systemic: Cardiac Disorder (diagnosed by MD)-Mild, Systemic: Chest Tightness / Heaviness / Pain-Mild, Systemic: Chills-Mild, Systemic: Confusion-Mild, Systemic: Diarrhea-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Fever-Mild, Systemic: patient eyes rolled in the back of the head and patient lost consciousness and went to ER in ambulance and patient is still there being checked out and may stay over night they did rule out a stroke-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Headache-Mild, Systemic: Heart Attack-Mild, Systemic: Hypertension-Mild, Systemic: Hyperventilation-Mild, Systemic: Hypotension-Mild, Systemic: Joint Pain-Mild, Systemic: Lymph Node Swelling-Mild, Systemic: MIS (Multisystem Inflammatory Syndrome)(diagnosed by MD)-Mild, Systemic: Nausea-Mild, Systemic: Neurological Disorder (diagnosed by MD)-Mild, Systemic: Numbness (specify: facial area, extremities)-Mild, Systemic: Seizure-Mild, Systemic: Shakiness-Mild, Systemic: Stroke-Mild, Systemic: Tachycardia-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild, Systemic: Tinnitus-Mild, Systemic: Unable to Sleep-Mild, Systemic: Visual Changes/Disturbances-Mild, Systemic: Vomiting-Mild, Systemic: Weakness-Mild, Additional Details: pt wife  needs to be contacted but pt was alert and in the hospital when called and checked on earlier, Other Vaccines:  VaccineTypeBrand: arexxy; Manufacturer: glaxosmith kline; LotNumber: 29z7e; Route: im; BodySite: left; Dose: 1; VaxDate: 09/04/2024, VaccineTypeBrand: shingrix; Manufacturer: glaxosmithkline; LotNumber: 4n9pf; Route: im; BodySite: left; Dose: 1; VaxDate: 09/04/2024, VaccineTypeBrand: tdap; Manufacturer: glaxosmithkline; LotNumber: cx4hl; Route: im; BodySite: right; Dose: 1; VaxDate: 09/04/2024